Analytics

CRO/Sponsor

Clinical Operations

Clinical Trial Supply Chain

DE&I

Data Management

Early Phase Development

Emerging Technology

Executive Roundtable

Feature Article

Industry Trends

Investigative Sites

Metrics and Benchmarks

Oncology

Online Extras

Patient Participation

Peer-Reviewed Articles

Protocol Design

Real World Evidence

Regulatory

Risk-Based Monitoring

Study Start-Up

Therapeutic Areas

Trial Design

Vendor Strategy & Collaboration

eClinical

mHealth

News

Publications

All Publications

E-Books

Media

Editorial Podcasts

Editorial Videos

Peer Exchange

Practice Academy

Conferences

Conference Coverage

Conference Listing

Columns

All Columns

A Closing Thought

Clinical Trial Insights

View from Brussels

View from Washington

Resources

Advertise

Blogs

Brand Insights

Events

Front & Center

White Papers

Webcasts

Subscribe

Latest solutions, case studies, interviews, practical articles for clinical trials operations, data management, technology, investigative sites and services.

About

Contact Us

Editorial Contacts

Do Not Sell My Personal Information

Privacy Policy

Terms and Conditions

Applied Clinical Trials Online

LinkedIN

Instagram

Facebook

Youtube

Soundcloud

Threads

Spotlight

Topic

1rem

Articles

Pharmaceutical research and development costs are growing faster than the market.1 This trend is important, because pharmaceutical companies finance R&D from a relatively fixed percentage (10%?20%) of global revenues.

Speeding the Critical Path

What learning science has taught us about the drivers and predictors of change—and applying those to clinical research practice. 


Can We Predict Trial Success? From ‘Feasibility’ to Predictive ‘Readiness’

As industry clinical trial partners seek greater patient diversity and operational efficiencies in drug development,  our October issue of Applied Clinical Trials  explores some of the related outsourcing methods that are emerging.

New Trends and Tactics in Outsourcing

A data-fueled framework for sponsors and CROs in navigating this shifting terrain.

The Strategic Emergence of Site Networks in Clinical Research

Overcoming this bias—which affects everything from trial design to data collection—is a critical obligation of clinical research stakeholders.


Optimism’s Hidden Costs: How the ‘Planning Fallacy’ Undermines Trial Success

Industry is turning to enhanced data collection methods in response to high demands for efficiency and profitability. 

The Evolution of Real-World Evidence: Moving Beyond Claims Data in Clinical Trials

"What does the general public not understand the most about clinical trials?" is the question we posed to three industry professionals. And their answers span only a few of the challenges that remain in patient education and knowledge about the clinical research enterprise. 

In this video, Kenneth Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development and Founder, Board Chair, CISCRP; Janice Chang, CEO of TransCelerate BioPharma, and Greg Ball, Safety Data Scientist and founder, ASAP Process Consulting present their views on the topic. 

Videos

"What does the general public not understand the most about clinical trials?" is the question we posed to three industry professionals at DIA 2023.

Public Misunderstandings Around Clinical Trials

Industry Trends

Latest News

More News